HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.
HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.
World AMR Awareness Week (WAAW) is a global campaign held from 18 to 24 November each year to raise awareness and drive action against antimicrobial resistance (AMR). Recognising WAAW provides an opportunity to reflect…
Read more
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) has recently published its Management of Vasomotor and Genitourinary Symptoms of Menopause (C-Gyn 9) guideline. This document is intended to support the…
Read more
Deucravacitinib has recently been approved for the treatment of adults with active psoriatic arthritis, expanding its therapeutic role beyond plaque psoriasis. Psoriatic arthritis is a chronic, autoimmune condition associated with psoriasis of the skin…
Read more
The Australian and New Zealand Society for Paediatric Endocrinology and Diabetes (ANZSPED) have recently updated their guidelines on the assessment and management of diabetes in children and adolescents. Type 2 diabetes is becoming increasingly…
Read more
Cytisine has recently been approved for use in Australia, making it the first new chemical entity registered specifically for smoking cessation in almost 20 years. Cytisine is a plant-derived alkaloid belonging to the same…
Read more
The Australian Commission on Safety and Quality in Health Care recently released the 2026 National Model for Clinical Governance, providing updated guidance on clinical governance to help health services deliver consistently high-quality care. The…
Read moreUpdated Guidelines on Vasomotor and Genitourinary Symptoms of Menopause (Oct. 30 2026)
Deucravacitinib for Psoriatic Arthritis (Oct. 23 2026)
Updated Guidelines for Type 2 Diabetes in Children and Adolescents (Oct. 16 2026)
A New Option for Smoking Cessation in Australia (Oct. 02 2026)
National Model for Clinical Governance (Sep. 18 2026)
Missed Medication Doses (Sep. 04 2026)
Chronic insomnia management using non-pharmacological practices (Aug. 21 2026)
Pneumococcal vaccine update (Aug. 07 2026)
An Overview of Hordeolum (Stye): Causes, Classification, Presentation and Treatment Strategies (Jun. 26 2026)
Pityriasis Lichenoides (Jun. 12 2026)
An Overview of Chronic Kidney Disease (May. 29 2026)
Dyshidrotic Eczema (May. 15 2026)
Psychotropic Medicines and Metabolic Monitoring (May. 01 2026)
Monoclonal Antibody Nomenclature: Understanding the Changes (Apr. 17 2026)
Dosing Considerations in Obesity (Apr. 03 2026)
Incident Reporting and Learning from Near Misses (Mar. 20 2026)
Updated Safety Information: Pegylated Liposomal Doxorubicin (Mar. 06 2026)
Infusion Reactions (Feb. 20 2026)
Abiraterone Formulations (Feb. 06 2026)
Hereditary Fructose Intolerance (Jan. 23 2026)
Safe Use of Long-acting Antipsychotic Injections (Jan. 09 2026)
Drug Interactions and Smoking (Dec. 26 2025)
Scheduling Changes for Vitamin B6 (Dec. 12 2025)
Deprescribing Clinical Practice Guideline (Nov. 28 2025)
Iron Injections (Nov. 14 2025)
New Resources to Guide Sepsis Care And Support (Oct. 31 2025)
Dopamine Dysregulation Syndrome (Oct. 17 2025)
From Compliance to Adherence to Concordance: The Evolution from Paternalistic Medicine to Patient Empowerment (Oct. 03 2025)
Dementia Action Week (15th – 21st September) (Sep. 19 2025)
Updates to the Recommendations for the Prevention of Infective Endocarditis (Sep. 05 2025)
Cholestatic Pruritus in Palliative Care (Aug. 22 2025)
Paracetamol and Metabolic Acidosis (Aug. 08 2025)
Angioedema During ACE Inhibitor Therapy (Jul. 25 2025)
Reducing Hospitalisation for COVID-19 (Jul. 11 2025)
Reducing Falls in Older Adults (May. 30 2025)
SGLT-2 Inhibitors – Beyond Diabetes (May. 16 2025)
Hypokalaemia (May. 02 2025)
Fluoroquinolone Adverse Reactions (Mar. 20 2025)
Buruli Ulcer (Mar. 07 2025)
Reporting Adverse Events (Feb. 21 2025)
Pharmacogenomics (Feb. 07 2025)
National Standard for Chronic Obstructive Pulmonary Disease (Jan. 24 2025)
Urinary Tract Infections and Diabetes Mellitus (Jan. 10 2025)
Antiemetics (Dec. 27 2024)
Upcoming Changes to Paracetamol Scheduling (Dec. 13 2024)
Dementia Literacy (Nov. 29 2024)
Allergies and Antimicrobial Resistance (Nov. 15 2024)
Respiratory Syncytial Virus (Nov. 01 2024)
Antibiotic-Associated Diarrhoea (Oct. 18 2024)
Medicines and Breastfeeding (Oct. 04 2024)
Safe Use of High-Risk Medications (Sep. 20 2024)
Benzyl Alcohol in Pharmaceutical Products (Sep. 06 2024)
Semaglutide for Weight Management (Aug. 23 2024)
Medication-Induced Taste Disorders (Aug. 09 2024)
Respiratory Syncytial Virus (Jul. 26 2024)
Overview of cephalosporins (Jul. 05 2024)
Iron Infusions (Jun. 21 2024)
Sulfites in Pharmaceutical Products (Jun. 07 2024)
Potentially Inappropriate Medicines in the Australian Setting (May. 24 2024)
Intranasal Corticosteroids in Allergic Rhinitis (May. 10 2024)
Updated COVID-19 Vaccine Recommendations (Apr. 26 2024)
Medication-Overuse Headache (Apr. 12 2024)
Data and Decisions for the Three Different CDK4/6 Inhibitors (Mar. 29 2024)
Changes Affecting Submissions for Unapproved Therapeutic Goods (Mar. 15 2024)
Pneumoccoccal Vaccines (Mar. 01 2024)
Potential Anaesthesia Risk with GLP-1 Agonists (Feb. 16 2024)
Mycobacterium bovis BCG for Bladder Cancer (Feb. 02 2024)
Patient Deterioration in the Healthcare Setting (Jan. 19 2024)
Comparison of different types of G-CSF (Jan. 05 2024)
Medications for the Management of Urinary Incontinence (Dec. 22 2023)
Oral Therapies in Metastatic Prostate Cancer (Dec. 08 2023)
Antifungal Resistance (Nov. 24 2023)
Evidence-based Non-drug Treatments in Dementia – Reminiscence Therapy (Nov. 10 2023)
An Overview of Fungi (Oct. 27 2023)
Lower Urinary Tract Symptoms in Men (Oct. 13 2023)
Weight Loss Medications (Sep. 29 2023)
Revised Hip Fracture Clinical Care Standard (Sep. 15 2023)
Antibiotic Use in the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Sep. 01 2023)
Erythropoietin Resistance (Aug. 18 2023)
Amiodarone-induced Thyroid Disorders (Aug. 04 2023)
Biological Therapies for Rheumatoid Arthritis (Jul. 21 2023)
Mineralocorticoid Receptor Antagonists (Jul. 07 2023)
Neo-Adjuvant Treatment of Melanoma and Directed Therapy from the PRADO Trial (Jun. 23 2023)
Anticoagulant-Related Nephropathy (Jun. 09 2023)
Sepsis (May. 26 2023)
Patient Self-Management (May. 12 2023)
The Role of the Pharmacist in Survivorship Care (Apr. 28 2023)
Recurrent Urinary Tract Infections in Women (Apr. 14 2023)
Enerzair® Breezhaler® (Mar. 31 2023)
Tirzepatide: a New Treatment for Type 2 Diabetes and Weight Loss (Mar. 17 2023)
Vedolizumab and Ustekinumab for the Treatment of Crohn’s Disease (Mar. 03 2023)
Wernicke-Korsakoff Syndrome (Feb. 17 2023)
Gestational Diabetes (Feb. 03 2023)
Glucagon-like Peptide-1 Receptor Agonists (Jan. 20 2023)
The Clinical Merits Associated with Utilising a Prescribing Pharmacist (Jan. 06 2023)
Improving Medication Use at Transitions of Care (Dec. 23 2022)
Vericiguat for Heart Failure (Dec. 09 2022)
Probiotics for Preterm Infants (Nov. 25 2022)
Updated Recommendations for the Dosing of Anticancer Drugs in Kidney Dysfunction (Nov. 11 2022)
Solid Oral Dose Forms and Swallowing Difficulties (Oct. 28 2022)
Vancomycin Use in Arthroplasty Patients (Oct. 14 2022)
Drug Holidays from Bisphosphonates (Sep. 30 2022)
Iron Deficiency Anaemia (Sep. 16 2022)
Drug-induced QT Interval Prolongation (Sep. 02 2022)
Monkeypox in Australia (Aug. 19 2022)
Anticholinergic Burden (Aug. 05 2022)
New Therapy for Cystic Fibrosis (Apr. 29 2022)
Seasonal Influenza Vaccination (Apr. 14 2022)
Paroxysmal Nocturnal Haemoglobinuria (Apr. 01 2022)
Aged Care and Chemical Restraint (Mar. 18 2022)
Molnupiravir for COVID-19 (Mar. 04 2022)
SGLT2 Inhibitors for Heart Failure (Feb. 18 2022)
COVID-19 Treatment Options (Feb. 04 2022)
What is Cancer Survivorship Care? (Jan. 21 2022)
Managing the Side Effects of Chemotherapy (Dec. 31 2021)
COVID-19 Vaccine Boosters (Dec. 17 2021)
Glucagon-like Peptide-1 Analogues (Dec. 03 2021)
Antimicrobial Awareness Week (Nov. 18 2021)
Restless Legs Syndrome (Nov. 05 2021)
Medication Interactions with Food (Oct. 21 2021)
Revised Delirium Clinical Care Standard (Oct. 08 2021)
Hepatitis B Reactivation (Sep. 23 2021)
Antimicrobial resistance: The need for stewardship (Sep. 08 2021)
Cannabis (Aug. 26 2021)
Melanoma – An Update in Treatment Strategies (Aug. 13 2021)
New Labelling Standard (Jul. 30 2021)
Prevention of Shingles (Jul. 16 2021)
Melatonin down scheduling: a brief update (Jul. 01 2021)
Topical treatment in psoriasis (Jun. 17 2021)
Progress of Cervical Cancer Elimination (Jun. 04 2021)
New Action Plan for Pain Management (May. 21 2021)
Thyroid Awareness Month (May. 06 2021)
Influenza Vaccines (Apr. 23 2021)
Treatment of Eosinophilic Oesophagitis (Apr. 09 2021)
Hospital-initiated Medication Reviews (Feb. 26 2021)
Boxed Warnings for Gabapentinoids (Feb. 10 2021)
COVID-19 Vaccines (Jan. 28 2021)
Updates to the Poisons Standard (Jan. 15 2021)
Active Ingredient Prescribing (Dec. 23 2020)
New Digital Mental Health Standards (Dec. 18 2020)
Approval of New Prescription Medications (Dec. 04 2020)
Antimicrobial Resistance (Nov. 20 2020)
Vaccines and Cold Chain (Nov. 06 2020)
Darolutamide (Nubeqa®) in Prostate Cancer (Oct. 22 2020)
Drugs in Sport (Oct. 09 2020)
Treatment of Infantile Haemangioma (Sep. 25 2020)
Abemaciclib for Breast Cancer (Sep. 11 2020)
Primary Cutaneous T-cell Lymphoma (Aug. 28 2020)
Gliflozins and Heart Failure (Aug. 12 2020)
Remdesivir – an emerging treatment for COVID-19 patients. (Jul. 31 2020)
Safe Injection Practices (Jul. 17 2020)
Diabetes and Insulin (Jul. 02 2020)
Hydroxychloroquine as triple therapy in COVID-19 patients (Jun. 16 2020)
Tocilizumab, COVID-19 and the cytokine storm (Jun. 03 2020)
Colchicine use in Acute Myocardial Infarction (May. 20 2020)
Changes to Opioid PBS Listings (May. 06 2020)
Coronavirus Disease (Apr. 22 2020)
Risk of Viral Transmission with Nebulised Medication Delivery (Apr. 09 2020)
Xerostomia (Feb. 27 2020)
Monoclonal Antibodies for Migraine (Feb. 13 2020)
Changes to Neural Connector Devices (Jan. 30 2020)
Venetoclax (Jan. 16 2020)
Biosimilars in Oncology (Jan. 03 2020)
Prescription Opioid Changes (Nov. 22 2019)
Diabetes Medications in the Peri-Operative Period (Nov. 08 2019)
Lamotrigine Dose Escalation (Oct. 25 2019)
Wilson Disease (Oct. 11 2019)
Parkinson’s Disease and Hospitalisation (Sep. 27 2019)
Understanding Clinical Trials (Sep. 13 2019)
Short-Course Oxycodone Packs (Aug. 30 2019)
Tafenoquine: A Novel Anti-Malarial (Aug. 16 2019)
Medicinal Marijuana? (Aug. 02 2019)
Primary Prevention: a Low-Dose Aspirin Story (Jul. 19 2019)
Hand-Foot Syndrome (Jul. 08 2019)
Low Dose Methotrexate for Rheumatoid Arthritis (Jun. 21 2019)
Introduction to the storage of medications in a private hospital setting (Jun. 07 2019)
Lactulose for Hepatic Encephalopathy (May. 24 2019)
Proton Pump Inhibitor Restrictions (May. 10 2019)
Prevention of Recurrent Clostridium difficile Infection (Apr. 25 2019)
Updates to the Australian Asthma Handbook (Apr. 12 2019)
Heparins (Mar. 29 2019)
Safety and Quality Standards for Mental Health (Mar. 15 2019)
Potentially Harmful Medication Use in the Elderly (Mar. 01 2019)
Animal-Assisted Therapy for Dementia (Feb. 15 2019)
Augmented Renal Clearance (Feb. 01 2019)
Biofilms (Jan. 18 2019)
Medications and Sun Exposure (Jan. 04 2019)
